Page last updated: 2024-10-22

albuterol and Abnormalities, Congenital

albuterol has been researched along with Abnormalities, Congenital in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibrahim, WH1
Rasul, F1
Ahmad, M1
Bajwa, AS1
Alamlih, LI1
El Arabi, AM1
Al-Mohannadi, D1
Siddiqui, MY1
Al-Sheikh, IS1
Ibrahim, AA1

Other Studies

1 other study available for albuterol and Abnormalities, Congenital

ArticleYear
Errors in Aerosol Inhaler Use and Their Effects on Maternal and Fetal Outcomes among Pregnant Asthmatic Women (Subanalysis from QAKCOP Study).
    Canadian respiratory journal, 2018, Volume: 2018

    Topics: Administration, Inhalation; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Budesonide; Budesonide,

2018